Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy De Backer

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
International Journal of Cardiology|November 8, 2005
The prevalence of concomitant hypertension and hypercholesterolaemia in the general populationDirk De Bacquer, Guy De Backer
International Journal of Cardiology|April 24, 2009
Predictive ability of the SCORE Belgium risk chart for cardiovascular mortalityDirk De Bacquer, Guy De Backer
Heart (British Cardiac Society)|March 27, 2014
Prevention of cardiovascular disease: new guidelines, new tools, but challenges remainJoep Perk, Ian Graham, Guy De Backer
European Journal of Preventive Cardiology|July 18, 2012
Do novel biomarkers add to existing scores of total cardiovascular risk?Guy De Backer, Ian Graham, Marie-Therese Cooney
The American Journal of Cardiology|August 28, 2007
Long-term prognostic value of p-wave characteristics for the development of atrial fibrillation in subjects aged 55 to 74 years at baselineDirk De Bacquer, Julie Willekens, Guy De Backer
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 21, 2007
Averting a pandemic health crisis in Europe by 2020: what physicians need to know regarding cholesterol managementAlberico L Catapano, Terje R Pedersen, Guy de Backer
Atherosclerosis|January 31, 2006
Epidemiological evidence for an association between habitual tea consumption and markers of chronic inflammationDirk De Bacquer, Els Clays, Joris Delanghe, et al.
European Journal of Preventive Cardiology|June 22, 2012
Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III surveyKornelia Kotseva, David Wood, Guy De Backer, et al.
European Journal of Preventive Cardiology|April 24, 2013
Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?Frederik Matthys, Tine De Backer, Guy De Backer, et al.
Vascular Health and Risk Management|February 5, 2014
Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER surveyRobert J Petrella, Guy Tremblay, Guy De Backer, et al.
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
International Journal of Cardiology|November 8, 2005
The prevalence of concomitant hypertension and hypercholesterolaemia in the general populationDirk De Bacquer, Guy De Backer
International Journal of Cardiology|April 24, 2009
Predictive ability of the SCORE Belgium risk chart for cardiovascular mortalityDirk De Bacquer, Guy De Backer
Heart (British Cardiac Society)|March 27, 2014
Prevention of cardiovascular disease: new guidelines, new tools, but challenges remainJoep Perk, Ian Graham, Guy De Backer
European Journal of Preventive Cardiology|July 18, 2012
Do novel biomarkers add to existing scores of total cardiovascular risk?Guy De Backer, Ian Graham, Marie-Therese Cooney
The American Journal of Cardiology|August 28, 2007
Long-term prognostic value of p-wave characteristics for the development of atrial fibrillation in subjects aged 55 to 74 years at baselineDirk De Bacquer, Julie Willekens, Guy De Backer
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 21, 2007
Averting a pandemic health crisis in Europe by 2020: what physicians need to know regarding cholesterol managementAlberico L Catapano, Terje R Pedersen, Guy de Backer
Atherosclerosis|January 31, 2006
Epidemiological evidence for an association between habitual tea consumption and markers of chronic inflammationDirk De Bacquer, Els Clays, Joris Delanghe, et al.
European Journal of Preventive Cardiology|June 22, 2012
Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III surveyKornelia Kotseva, David Wood, Guy De Backer, et al.
European Journal of Preventive Cardiology|April 24, 2013
Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?Frederik Matthys, Tine De Backer, Guy De Backer, et al.
Vascular Health and Risk Management|February 5, 2014
Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER surveyRobert J Petrella, Guy Tremblay, Guy De Backer, et al.
Pageof 22